Search - tctmd.com

Displaying 401 - 420 of 1670

Sort: Relevancy | Date

Presentation TCT 2019

Getting Optimal Arterial and Venous Access for Large-Bore Catheter Procedures

Presenter: Michael Rinaldi

September 27, 2019

Presentation TCT 2019

Case Presentation: A Patient at High Bleeding Risk and CAD- Real Management Dilemmas

Presenter: Davide Cao, MD

September 27, 2019

Presentation TCT 2019

Welcome and Introductions

Presenter: Roxana Mehran

September 27, 2019

News TCT 2019

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Shelley Wood

September 26, 2019

https://www.tctmd.com/news/ideal-lm-probes-short-dapt-and-bioabsorbable-polymer-stent-left-main-disease

News Conference News TCT 2019

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Michael O'Riordan

September 26, 2019

Presentation TCT 2019

Case #3: Transcatheter Tricuspid Therapy for Severe TR

Presenter: Christine Chung

September 25, 2019

Presentation TCT 2019

Case #2: Mitral Valve-in-MAC

Presenter: Stephanie El-Hajj

September 25, 2019

Presentation TCT 2019

Case #1: Complex TAVR ⁠— Bioprosthetic Valve Failure

Presenter: Maureen McKiernan

September 25, 2019

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

News Opinion Fellow Talk

What I Am Most Looking Forward to at TCT 2019

Mahesh V. Madhavan, MD

September 18, 2019

News Industry News

Abbott Announces European Approval Of Two Life-Saving Heart Devices For Babies And Children

September 17, 2019

News CV Team Pro

The Providence St. Vincent Medical Center Cath Lab Team

L.A. McKeown

September 12, 2019

News Conference News ESC 2019

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

Todd Neale

September 11, 2019

News Daily News

Early Signs Positive for Tendyne TMVR in Severe MAC

Caitlin E. Cox

September 11, 2019

News Conference News ESC 2019

BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI

Caitlin E. Cox

September 10, 2019

News Conference News ESC 2019

LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17

Todd Neale

September 10, 2019

News Industry News

Abbott Announces New Data That Shows Artificial Intelligence Technology Can Help Doctors Better Determine Which Patients Are Having A Heart Attack

September 10, 2019

News Industry News

NobleStitch™ EL Receives Approval Of IDE To Conduct A Trial For Reduction Of Recurrent Ischemic Stroke

September 05, 2019

News Industry News

Abbott Launches World's First Pivotal Trial To Test New Approach For Repairing Leaky Tricuspid Heart Valves

September 05, 2019

News Conference News ESC 2019

MITRA-FR at 2 Years: Still No Benefit of MitraClip Over Meds

Shelley Wood

September 02, 2019

Advertisement

Getting Optimal Arterial and Venous Access for Large-Bore Catheter Procedures

Case Presentation: A Patient at High Bleeding Risk and CAD- Real Management Dilemmas

Welcome and Introductions

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Case #3: Transcatheter Tricuspid Therapy for Severe TR

Case #2: Mitral Valve-in-MAC

Case #1: Complex TAVR ⁠— Bioprosthetic Valve Failure

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

What I Am Most Looking Forward to at TCT 2019

Abbott Announces European Approval Of Two Life-Saving Heart Devices For Babies And Children

The Providence St. Vincent Medical Center Cath Lab Team

Reduced-Dose Rivaroxaban May Be an Option After LAA Occlusion, ADRIFT Hints

Early Signs Positive for Tendyne TMVR in Severe MAC

BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI

LAA Occluders, NOACs Provide Similar Outcomes in High-risk A-fib Patients: PRAGUE-17

Abbott Announces New Data That Shows Artificial Intelligence Technology Can Help Doctors Better Determine Which Patients Are Having A Heart Attack

NobleStitch™ EL Receives Approval Of IDE To Conduct A Trial For Reduction Of Recurrent Ischemic Stroke

Abbott Launches World's First Pivotal Trial To Test New Approach For Repairing Leaky Tricuspid Heart Valves

MITRA-FR at 2 Years: Still No Benefit of MitraClip Over Meds

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content